These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2868365)

  • 21. HTLV-III antibody in intravenous drug abusers of metropolitan Barcelona, Spain.
    Tor J; Muga R; Argelagues E; Rey-Joly C; Foz M; Ribas-Mundó M
    Arch Intern Med; 1986 Apr; 146(4):805. PubMed ID: 3008680
    [No Abstract]   [Full Text] [Related]  

  • 22. HTLV-III infection in Canada in 1985.
    Neumann PW; Benning BJ; Robinson DG; Gilmore N; O'Shaughnessy MV
    CMAJ; 1986 Sep; 135(5):477-80. PubMed ID: 3461870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Anti-HTLV III/LAV antibodies of the IgM class in subjects at risk with negative anti-HTLV III/LAV IgG ELISA results (preliminary results)].
    Bedarida G; D'Agostino F; Ronsivalle MG; Berto E; Cambiè G; Berto N; Grisi ME; Arcidiacono I; Sterza G
    Riv Emoter Immunoematol; 1986; 33(1):75-87. PubMed ID: 3532290
    [No Abstract]   [Full Text] [Related]  

  • 24. Role of hepatitis B virus in acquired immunodeficiency syndrome.
    Ravenholt RT
    Lancet; 1983 Oct; 2(8355):885-6. PubMed ID: 6137700
    [No Abstract]   [Full Text] [Related]  

  • 25. A stage model of HTLV-III LAV infection in intravenous drug users.
    Des Jarlais DC; Friedman SR; Spira TJ; Zolla-Pazner S; Marmor M; Holzman R; Mildvan D; Yancovitz S; Mathur-Wagh U; Garber J
    NIDA Res Monogr; 1986; 67():328-34. PubMed ID: 3018574
    [No Abstract]   [Full Text] [Related]  

  • 26. [HTLV-III infection in risk groups].
    Esteban R; Buti M; Esteban JI; Hernández JM; Jardí R; Vila M; Tusell J; Guardia J
    Med Clin (Barc); 1986 Jan; 86(3):110-2. PubMed ID: 3007880
    [No Abstract]   [Full Text] [Related]  

  • 27. Antibody to LAV, the putative agent of AIDS, in parenteral drug abusers and methadone-maintained patients: therapeutic, historical, and ethical aspects.
    Novick DM; Kreek MJ; Des Jarlais DC; Spira TJ; Khuri ET; Ragunath J; Kalyanaraman VS; Gelb AM; Miescher A
    NIDA Res Monogr; 1986; 67():318-20. PubMed ID: 3092085
    [No Abstract]   [Full Text] [Related]  

  • 28. Antibody to HIV in patients with acute hepatitis B in the period 1975-1984.
    Arendrup M; Lindhardt BO; Krogsgaard K; Gaub J; Nielsen JO
    Scand J Infect Dis; 1987; 19(2):167-72. PubMed ID: 3475776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of HTLV-III/LAV antibody in selected populations in Thailand.
    Wangroongsarb Y; Weniger BG; Wasi C; Traisupa A; Kunasol P; Rojanapithayakorn W; Fucharoen S
    Southeast Asian J Trop Med Public Health; 1985 Dec; 16(4):517-20. PubMed ID: 3869739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Chronic generalized lymphadenopathy with splenomegaly associated with HTLV-III virus antibodies].
    Mijović A; Stevanović G; Brkić S; Dimitrijević M; Rolović Z; Ruvidić R
    Srp Arh Celok Lek; 1986 Jan; 114(1):109-20. PubMed ID: 3014667
    [No Abstract]   [Full Text] [Related]  

  • 31. Rapid spread of HTLV-III infection among drug addicts in Italy.
    Angarano G; Pastore G; Monno L; Santantonio T; Luchena N; Schiraldi O
    Lancet; 1985 Dec; 2(8467):1302. PubMed ID: 2866362
    [No Abstract]   [Full Text] [Related]  

  • 32. Vertical transmission of HTLV-III.
    Chiodo F; Ricchi E; Costigliola P; Michelacci L; Bovicelli L; Dallacasa P
    Lancet; 1986 Mar; 1(8483):739. PubMed ID: 2870247
    [No Abstract]   [Full Text] [Related]  

  • 33. [Occurrence of HTLV-III infection and related clinical forms in a homogeneous group of drug addicts. Significance of immunologic changes and evaluation of risk factors].
    Tassinari MC; Gualandi M; Guerra G; Barbieri D; Benassi N; Lazzarato M; Dallara G; Gallerani M
    Recenti Prog Med; 1986 Oct; 77(10):461-5. PubMed ID: 3547522
    [No Abstract]   [Full Text] [Related]  

  • 34. [Visceral leishmaniasis associated with positive anti-HTLV III antibody].
    Verdejo J; Alvar J; Polo RM; González Lahoz JM
    Rev Clin Esp; 1987 Mar; 180(4):221. PubMed ID: 3647541
    [No Abstract]   [Full Text] [Related]  

  • 35. Prevalence of HBV HDV and LAV/HTLV-III infections among Greek drug addicts.
    Roumeliotou-Karayannis A; Tassopoulos N; Kotsianopoulou M; Karpodini E; Trichopoulou E; Papaevangelou G
    Prog Clin Biol Res; 1987; 234():403-4. PubMed ID: 3628397
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevalence of HTLV-III/LAV antibodies among Haitians.
    Pitchenik AE; Spira TJ; Elie R; Fischl MA; Getchell JP; Arnoux E; Pierre GD; Laroche AC; Guerin JM; Malebranche R
    N Engl J Med; 1985 Jun; 312(26):1705-6. PubMed ID: 3858670
    [No Abstract]   [Full Text] [Related]  

  • 37. Prevalence of HTLV-III/LAV antibodies in patients with hemophilia and in their sexual partners in France.
    Allain JP
    N Engl J Med; 1986 Aug; 315(8):517-8. PubMed ID: 3016541
    [No Abstract]   [Full Text] [Related]  

  • 38. LAV/HTLV-III seroconversion and disease in hemophiliacs treated in France.
    Mathez D; Leibovitch J; Sultan Y; Maisonneuve P
    N Engl J Med; 1986 Jan; 314(2):118-9. PubMed ID: 3079879
    [No Abstract]   [Full Text] [Related]  

  • 39. [Infection with the hepatitis B virus (HBV), the human T-lymphotropic retrovirus (HIV) and Treponema pallidum in jailed minors].
    Migneco G; Valentino L; Navetta A; Lampiasi AM; Bagnasco D; Lupo G
    Boll Soc Ital Biol Sper; 1987 Mar; 63(3):241-5. PubMed ID: 3307838
    [No Abstract]   [Full Text] [Related]  

  • 40. HTLV-III seropositivity in 1971-1972 parenteral drug abusers--a case of false positives or evidence of viral exposure?
    Moore JD; Cone EJ; Alexander SS
    N Engl J Med; 1986 May; 314(21):1387-8. PubMed ID: 3010112
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.